Marker Therapeutics, Inc. (MRKR)
2.05
-0.14
(-6.39%)
USD |
NASDAQ |
Jan 22, 16:00
2.05
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Free Cash Flow: -14.82M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Viridian Therapeutics, Inc. | -326.34M |
| ADMA Biologics, Inc. | 40.61M |
| Kiniksa Pharmaceuticals International Plc | 101.73M |
| Neurocrine Biosciences, Inc. | 593.10M |
| AIM ImmunoTech, Inc. | -13.33M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.736M |
| Cash from Financing (Quarterly) | 9.864M |
| Free Cash Flow Per Share (Quarterly) | -0.1633 |
| Free Cash Flow to Equity (Quarterly) | -2.736M |
| Free Cash Flow to Firm (Quarterly) | -2.736M |
| Free Cash Flow Yield | -56.78% |